Çakar, S.; Arslan, N.; Ateş, M.; Sayın, O.; Akyaz, O.; Tatar Arık, T.; Ilgın, R.; Danış, N.
Serum LEAP-2 as a Potential Biomarker for Hepatic Steatosis in Adolescents with Obesity and MASLD: A Cross-Sectional Study. Diagnostics 2025, 15, 2816.
https://doi.org/10.3390/diagnostics15212816
AMA Style
Çakar S, Arslan N, Ateş M, Sayın O, Akyaz O, Tatar Arık T, Ilgın R, Danış N.
Serum LEAP-2 as a Potential Biomarker for Hepatic Steatosis in Adolescents with Obesity and MASLD: A Cross-Sectional Study. Diagnostics. 2025; 15(21):2816.
https://doi.org/10.3390/diagnostics15212816
Chicago/Turabian Style
Çakar, Sevim, Nur Arslan, Mehmet Ateş, Oya Sayın, Oğuzhan Akyaz, Tuğçe Tatar Arık, Rabia Ilgın, and Nilay Danış.
2025. "Serum LEAP-2 as a Potential Biomarker for Hepatic Steatosis in Adolescents with Obesity and MASLD: A Cross-Sectional Study" Diagnostics 15, no. 21: 2816.
https://doi.org/10.3390/diagnostics15212816
APA Style
Çakar, S., Arslan, N., Ateş, M., Sayın, O., Akyaz, O., Tatar Arık, T., Ilgın, R., & Danış, N.
(2025). Serum LEAP-2 as a Potential Biomarker for Hepatic Steatosis in Adolescents with Obesity and MASLD: A Cross-Sectional Study. Diagnostics, 15(21), 2816.
https://doi.org/10.3390/diagnostics15212816
